By Kim Richters

Roche Holding AG (RO.EB) said Monday that it has extended the offer period for its planned takeover of biotechnology company Spark Therapeutics Inc. (ONCE) to Dec. 16.

Swiss pharmaceutical company Roche said the offer was extended to provide additional time for the U.S. Federal Trade Commission and the U.K. Competition and Markets Authority to complete their reviews of the pending acquisition.

The period for Roche's offer of $114.50 per share has been extended several times and was set to expire on Dec. 10.

As of Dec. 6, around 14.9% of Spark's outstanding shares had been tendered, according to Roche.

Write to Kim Richters at kim.richters@wsj.com

(END) Dow Jones Newswires

December 09, 2019 02:01 ET (07:01 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Onconetix (NASDAQ:ONCE)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Onconetix Charts.
Onconetix (NASDAQ:ONCE)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Onconetix Charts.